Enveric Biosciences Inc
General ticker "ENVB" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $3.0M
Enveric Biosciences Inc does not follow the US Stock Market performance with the rate: -39.7%.
Estimated limits based on current volatility of 4.1%: low 0.31$, high 0.34$
Factors to consider:
- Price in estimated range
- Earnings for 18 months up through Q2 (+1 year) exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [0.68$, 3.75$]
- 2023-12-31 to 2024-12-30 estimated range: [0.22$, 1.15$]
Financial Metrics affecting the ENVB estimates:
- Negative: Non-GAAP EPS, $ of -16.45 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -82.66 <= 2.35
- Negative: Industry inventory ratio change (median), % of 3.13 > 0.49
- Negative: Industry earnings per price (median), % of -20.11 <= 1.31
Short-term ENVB quotes
Long-term ENVB plot with estimates
Financial data
YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|
Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
Operating Expenses | $5.62MM | $64.62MM | $27.42MM |
Operating Income | $-5.62MM | $-64.62MM | $-27.42MM |
Non-Operating Income | $-1.25MM | $8.19MM | $7.46MM |
Interest Expense | $0.45MM | $0.01MM | $0.01MM |
R&D Expense | $0.17MM | $4.79MM | $8.03MM |
Income(Loss) | $-6.86MM | $-56.43MM | $-19.96MM |
Taxes | $0.00MM | $-7.45MM | $-1.49MM |
Profit(Loss) | $-6.86MM | $-48.98MM | $-18.47MM |
Stockholders Equity | $3.42MM | $22.31MM | $14.67MM |
Assets | $4.10MM | $26.72MM | $19.55MM |
Operating Cash Flow | $-3.89MM | $-11.46MM | $-17.15MM |
Capital expenditure | $0.04MM | $0.86MM | $0.58MM |
Investing Cash Flow | $-0.04MM | $2.19MM | $-0.58MM |
Financing Cash Flow | $5.53MM | $24.90MM | $18.18MM |
Earnings Per Share* | $-55.50 | $-103.69 | $-12.77 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.